Kristin Yarema
2023
In 2023, Kristin Yarema earned a total compensation of $2.4M as President, Cell Therapy at Poseida Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $171,280 |
---|---|
Option Awards | $934,210 |
Salary | $380,625 |
Stock Awards | $934,910 |
Other | $13,540 |
Total | $2,434,565 |
Yarema received $934.9K in stock awards, accounting for 38% of the total pay in 2023.
Yarema also received $171.3K in non-equity incentive plan, $934.2K in option awards, $380.6K in salary and $13.5K in other compensation.
Rankings
In 2023, Kristin Yarema's compensation ranked 400th out of 2,790 executives tracked by ExecPay. In other words, Yarema earned more than 85.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 400 | 86th |
Manufacturing | 228 | 85th |
Chemicals And Allied Products | 161 | 82nd |
Drugs | 158 | 81st |
Biological Products, Except Diagnostic Substances | 57 | 72nd |
Yarema's colleagues
We found two more compensation records of executives who worked with Kristin Yarema at Poseida Therapeutics in 2023.